The largest database of trusted experimental protocols

2 2 dithiodipyridine

Manufactured by Merck Group
Sourced in United States

2,2′-dithiodipyridine is a laboratory reagent used in various analytical and synthetic applications. It is a colorless crystalline solid with a molecular formula of C10H8N2S2. The product's core function is to serve as a sulfhydryl-reactive agent, facilitating the detection and quantification of thiol-containing compounds.

Automatically generated - may contain errors

7 protocols using 2 2 dithiodipyridine

1

Formation of SNARE Complex Template

Check if the same lab product or an alternative is used in the 5 most similar protocols
Before complex formation, TCEP was removed from each protein preparation using Superdex 75 10/300 GL column. TCEP-free Syb (100 to 200 μM) was mixed with 400 to 500 μM 2,2-dithiodipyridine (Sigma-Aldrich). The reaction was monitored at 343 nm using an Agilent 8453 ultraviolet-visible spectrometer. Upon completion, the excess of 2,2-dithiodipyridine was removed using a PD MiniTrap G-25 Sephadex column with 100 mM phosphate at pH 7.0, 100 mM NaCl, 6 M urea, and 0.2 mM EDTA as the elution buffer. An excess of activated Syb was then mixed with TCEP-free SyxLE and left incubated at room temperature overnight. The efficiency of disulfide bond formation between Syb and SyxLE was estimated on the basis of the absorbance at 343 nm. The SyxLE/Syb conjugate was purified by size exclusion chromatography using Superdex 75 10/300 GL and 20 mM Hepes (pH 7.4), 150 mM KCl as the running buffer. TCEP-free Munc18-1 D326K was then mixed with purified SyxLE/Syb and left rotated overnight at room temperature. The template complex was finally purified by size exclusion chromatography using a Superdex 75 10/300 GL column in 20 mM Hepes (pH 7.4) with 150 mM KCl.
+ Open protocol
+ Expand
2

Zn2+ Ejection from SARS-CoV-2 Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Zn2+-ejecting
agents were purchased from Sigma-Aldrich (USA), including 2,2′-dithiobis(benzothiazole),
cystamine dihydrochloride, 5,5′-dithiobis(2-nitrobenzoic acid)
(DTNB), phenyl disulfide, 3-nitrobenzamide, tetraethylthiuram disulfide
(disulfiram), 2,2′-dithiodipyridine, (±)alpha-lipoic acid,
ebselen, and cisplatin. The Zn2+-specific fluorophore FluoZinTM-3
(Invitrogen/Life Technologies) was used to monitor the release of
Zn2+ ions from SARS-CoV-2 nsp13 and nsp14. The Zn2+-ejecting agents were dissolved in DMSO to a stock solution of 100
μM. SARS-CoV-2 His-tagged nsp13 (5 μM) and nsp14 (5 μM)
were respectively mixed with each Zn2+-ejecting agent (5
μM) and FluoZin-3 (1 μM) in a total reaction volume of
200 μL at room temperature. Fluorescence emission was then measured
by EnSpire Multilabel Plate Reader (PerkinElmer, USA) at an excitation
wavelength of 494 nm and emission wavelength of 516 nm.
+ Open protocol
+ Expand
3

Synthesis of Peptide-Drug Conjugates

Check if the same lab product or an alternative is used in the 5 most similar protocols
All required organic solvents were purchased from Wilkem Scientific (Pawtucket, RI, USA). The Fmoc-protected building block of amino acids, including Fmoc-Trp(Boc)-OH, Fmoc-Arg(Pbf)-OH, Dde-K(Boc)-OH, BocAla-OH, 3-(tritylthio)propionic acid, and H-Trp(Boc)-2-chlorotrityl resin, were purchased from Chem-Impex International Inc. (Wood Dale, IL, USA). Hydroxy-7-azabenzotriazole (HOAT), 1,3-diisopropylcarbodiimide (DIC), O-(benzotriazole-1-yl)-N,N,N’,N’-tetramethyluroniumhexafluorophosphate (HBTU), benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate (PyBOP), and hydroxybenzotriazole (HOBt), glutaric anhydride (95%), triphosgene (99%), 4-dimethylaminopyridine (DMAP, 99%), N,N-diisopropylethylamine (DIPEA), triethylamine (TEA), β-mercaptoethylamine hydrochloride (cystamine hydrochloride), and 2,2′-dithiodipyridine were purchased from Sigma-Aldrich Chemical Co. (Milwaukee, WI, USA). Camptothecin (CPT) was purchased from Santa Cruz Biotech, Inc. (Dallas, TX, USA) and Paclitaxel (PTX) was purchased from Euroasias Group Inc. (Woodbridge, NJ, USA).
+ Open protocol
+ Expand
4

Spin Label and Redox Assay Reagents

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following chemicals were purchased from Sigma Chemical Co. (St. Louis, MO, USA): 4-iodoacetamide-TEMPO (iodoacetamide spin label; ISL), 4-Amino-TEMPO (tempamine), 2, 4, 6-tripyridyl-s-triazine (TPTZ), o-phthalaldehyde (OPA), xylenol orange, 5-dithiobis-2-nitrobenzoic acid (DTNB), acetylthiocholine iodide, 2, 4-dinitrophenylhydrazine (DNPH), and 2, 2′-dithiodipyridine. Bis-(2, 2, 5, 5-tetramethyl-3-imidazoline-1-oxyl-4-yl) disulfide biradical (•RSSR•) was obtained from Enzo Life Sciences, Inc. (New York, USA). All other reagents of analytical purity were obtained from POCH S.A. (Gliwice, Poland).
+ Open protocol
+ Expand
5

Silica-Filled Styrene-Butadiene Rubber Compounding

Check if the same lab product or an alternative is used in the 5 most similar protocols
(3-mercaptopropyl)methyldimethoxysilane (MPDMS, ≥95%), 2,2’-dithiodipyridine, dichloromethane (anhydrous, 99.8%), petroleum ether, and isopropyl alcohol (IPA, 99.7%) were purchased from Sigma-Aldrich, St. Louis, MO, USA. SBR 1723 (styrene content: 23.5%, oil type: TDEA 37.5 phr, mooney viscosity (ML1 + 4): 49, coagulant: acid salt) was obtained from Kumho Petrochemical, Seoul, Korea. F-175 silica cake (pH: 7.0, loss on drying/105 °C × 2H: 6.0%, ignition loss at 1000 °C: 13.0%, oil absorption: 250 mL/100 g, Brunaeur–Emmett–Teller (BET): 175 m2/g) was purchased from Namhae Chemical, Yeosu, Korea. Bis[3-(triethoxysilyl)propyl] disulfide (TESPD (Si-75)) was purchased from Evonik Industries, Essen, Germany. Sodium hydroxide (NaOH, ≥96%) was obtained Samchun, Seoul, Korea. Various compounding processing additives such as zinc oxide (ZnO), stearic acid (S/A), and N-(1,3-dimethyl-butyl)-N’-phenyl-p-phenylenediamine (6PPD) were purchased from Sigma-Aldrich, USA. In the final compounding step, sulfur (Samchun, Seoul, Korea) was used as a crosslinking agent. N-cyclohexyl-2-benzothiazole sulfonamide (CBS) (Tokyo Chemical Industry, Tokyo, Japan) and diphenyl guanidine (DPG, Sigma-Aldrich, St. Louis, MO, USA) were used as crosslinking accelerators.
+ Open protocol
+ Expand
6

Synthesis and Purification of Thiol-Modified Oligonucleotides

Check if the same lab product or an alternative is used in the 5 most similar protocols
1.0 mg of an oligonucleotide (Biomers) composed of 30 cytosines with a 5′-thiol (hexamethylene linker) and a 3′-biotin (triethylene glycol spacer) was dissolved in 1 mL of 10 mM Tris·HCl, 1 mM EDTA, 5 mM TCEP, pH 7.5. After heating at 65 °C for 1.5 h, TCEP was removed with an Amicon Ultra column (0.5 mL, 3 kDa). The reduced oligonucleotide was then treated with the maleimide-CBT crosslinker (15 equivalents dissolved in a minimal volume of dimethyl sulfoxide) at room temperature for 2 h. The modified oligonucleotide (5′-CBT-oligo(dC)30-biotin-3′) was purified by ion-exchange chromatography on a monoQ FF Sepharose column (GE Healthcare) with an AKTApurifier FPLC (GE Healthcare) eluted with 0–1 M KCl in TE buffer (10 mM Tris·HCl, 1 mM EDTA, pH 8.0). The identity of the product was confirmed by MS (Supplementary Fig. 1c–f).
5′-S-thiopyridyl-oligo(dA)30-biotin-3′ was synthesized by incubating 1.0 mg of a reduced oligonucleotide composed of 30 adenines with a 5′-thiol (hexamethylene linker) and a 3′-biotin (triethylene glycol spacer) with 20 mM 2,2′-dithiodipyridine (Sigma) in acetonitrile for 2 h at room temperature (Supplementary Fig. 3b). The modified oligonucleotide was purified by ion-exchange chromatography on the monoQ FF Sepharose column.
+ Open protocol
+ Expand
7

Synthesis of Multifunctional Polymer Therapeutics

Check if the same lab product or an alternative is used in the 5 most similar protocols
All reagents were from commercial sources and used as received. All chemicals, 4-cyano-4-(phenylcarbonothioylthio)pentanoic acid, poly(ethyleneglycol)methylether(4-cyano-4-pentanoate dodecyl trithiocarbonate) (average Mw 1400, 5400, 10000), methacryloyl chloride, dichloromethane (DCM), triethylamine (TEA), 2,2’-dithiodipyridine, 2-mercaptoethanol, benzyl methacrylate, butyl methacrylate, tris(2-carboxyethyl)phosphine hydrochloride, glutathione (GSH), were obtained from Sigma-Aldrich; camptothecin, rapamycin, and paclitaxel were obtained from Selleckchem. All chemicals were used without further purification unless otherwise mentioned. 2,2′-Azobis-(2-methylpropionitrile) (AIBN) was procured from Sigma-Aldrich and purified by recrystallization before usage. Tetrahydrofuran (THF) was freshly distilled before each use. Other molecules without synthetic details shown were prepared using previously reported procedures.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!